esmit@eanm.org

Quantitative Nuclear Medicine Imaging

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

Nuclear medicine is a quantitative imaging modality. However, its power and its vulnerabilities are not always appreciated. In this course, we will explore the formation of SPECT/CT and PET/CT imaging, and how, with corrections they can provide us with quantitative imaging biomarkers. We will look at different forms of quantification from kinetic modelling to activity concentration to SUV and explain how they can be used in a clinical environment. Finally, we will look at how scanner developments, software developments and Artificial Intelligence is influencing our field. In this course formal lectures will be supplemented with practical sessions and open discussions about Quantification in Nuclear Medicine.

€950

Early Bone SPECT in Clinical Practice

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

Early phase SPECT has the potential to expand the diagnosis spectrum of disphosphonate scintigraphy in non-oncologic situations. Incorporated in a clinical routine, it has the ability to focus the nuclear medicine physician attention on the most inflammatory lesions whichever they might be osseous, para-osseous ou extra-osseous. Our 1.5 day course is intended to be a […]

€950

Prostate Cancer Theranostics

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used for the diagnosis (i.e., staging and restaging) and treatment of patients with prostate cancer. Radionuclide PSMA therapy is a useful new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and potentially also in patients with hormone-sensitive prostate cancer. The course will cover the spectrum of […]

€950